Improve International has announced that it is to launch new 'mini-modular' courses in dentistry, oncology, neurology and ultrasound for those practitioners that want to develop a more in-depth knowledge than they would gain from a one-day course without undertaking a Certificate.
The courses, which begin in the Autumn, include two days of study each month for three months, making six days of CPD in total. Ultrasound delegates study for two days each month for two months, making four days of CPD in total. Each course, with the exception of Neurology, contains a practical element.
David Babington MRCVS, Managing Director of Improve, said: "Veterinary surgeons wanting to develop specialist skills in specific areas currently have two choices - either to embark on a full-scale Certificate programme or to attend one day sessions in their area of interest. For those without the time or resource to commit to a Certificate programme but who are keen to develop their skills to a high level, attending a one-day course may not give them the expertise - or the practical experience - they seek."
He continued: "Our Mini-Modular courses aim to bridge that gap. They are high quality programmes, led by recognised international experts, and each gives a thorough grounding in the subject, specifically geared to the requirements of the small animal general practitioner. They aim to give delegates in-depth knowledge, practical experience and the confidence to take their new skills back into practice."
The Mini-Modular courses are open to veterinary surgeons from across Europe with teaching based at Improve's training headquarters in Swindon, which offer wet-lab facilities.
For further information, visit www.improveinternational.com or call 01793 759159.
The Welsh Government Deputy Minister for Farming and Food, Rebecca Evans, has officially opened the new Wales Veterinary Science Centre.
The centre, which is located on the site of the former Animal and Plant Health Agency's (APHA) Veterinary Investigation Centre, has been established by Iechyd Da, a consortium of independent veterinary practices based in Wales together with Welsh Lamb and Beef Producers Ltd, and Aberystwyth University.
Iechyd Da was recently appointed by APHA as a third party provider to deliver expert post-mortem examinations of new and re-emerging diseases of farm animals. The service has been operational since April 2015.
Deputy Minister Rebecca Evans AM said: "I am pleased to officially open the Wales Veterinary Science Centre, which will significantly strengthen and enhance the important contribution the veterinary profession makes to rural life in Wales and raises standards of animal health and welfare. It will also bolster the rural economy by securing technical jobs for the area, benefit the wider economy by supporting our farming communities, and be an asset to the UK by contributing valuable data to the surveillance network."
Professor Christianne Glossop, Chief Veterinary Officer for Wales said: "The Centre will have a significant role in the protection of animals in Wales and will provide an important contribution to a successful and resilient farming industry, reflecting the essential role of the veterinary profession in Wales."
Phil Thomas, Director of Iechyd Da said: "Iechyd Da now looks forward to building on the post-mortem provision already available so that we can provide a range of services, from running training courses for animal keepers to dissection classes for students, continuous professional development for practicing vets, and supporting disease eradication schemes. The vision is of a One Health institute that recognises the interlocking, overlapping relationships between people, livestock, the wildlife and the environment around us."
Richard Irvine, Head of Scanning Surveillance and the Surveillance Intelligence Unit at the Animal and Plant Health Agency (APHA) said: "I look forward to APHA working in close partnership with the Wales Veterinary Science Centre to provide expert diagnostic support and surveillance intelligence for veterinary practices and farmers in Wales. Only by working together can we create an effective disease surveillance network, and I urge farmers and vets in Wales to make use of the considerable expertise that exists within the Wales Veterinary Science Centre and APHA."
Centaur Services has launched a range of health supplement soft chews for cats and dogs which can be ordered in custom, practice-branded packaging.
Centaur says the practice branding is designed to reinforce client relationships by encouraging clients to buy vet-recommended products direct from the practice, thereby reducing the loss of sales to the high street or online stores.
The chews consist of a flavoured base with a crumbly texture, into which various health supplements are blended. Centaur says they are particularly popular with owners who find it difficult to encourage their pets to consume supplements within harder carriers, as the soft chews are more akin to food and easier for the animals to consume.
Colm McGinn, Sales and Marketing Director of Centaur Services, said: "We're always looking for ways to innovate the offer we provide to our customers and make their businesses more successful. Not only are the chews a high quality product with excellent health benefits for pets, they also offer practices a new way of engaging with their clients by providing own-labelled products that come not only with the recommendation of their vet but also the trusted brand of the practice."
The chews are launching in five varieties. For dogs, there's joint support and a heart-shaped multi-vitamin. For cats, there's joint support, bladder support and hairball relief. Additional varieties are in development.
For more information call Centaur Services on 01963 350005 to arrange a visit, or for existing customers, contact your Territory Manager.
Virbac has launched Sulfatrim, the first veterinary-licensed Trimethoprim and Sulfamethoxazole (TMPS) oral antibiotic for use in rabbits, pigeons and bearded dragons.
Kate Woolley MRCVS, Product Manager, said: "Until now, no similar veterinary-licensed product has been available for these species and, in an environment where vets are increasingly aware of the responsible use of antibiotics across all species, we are very happy to launch Sulfatrim, the first licensed TMPS for rabbits, pigeons and bearded dragons."
Sulfatrim is presented in a 30ml bottle with a dispensing cap and syringe.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
Kruuse has announced that it has entered into an agreement with Henry Schein Inc., under which the American supplier of veterinary, dental and medical healthcare products and services will acquire a majority shareholding in the company.
Under the agreement - the financial details of which are not being disclosed - the Kruuse family will retain the remaining shareholding and work with Henry Schein to accelerate global expansion of the company.
Kruuse and Henry Schein have already been business partners in the marketing and distribution of animal healthcare products. Kruuse says it expects the deal to create significant growth prospects, particularly for its own products and brands which will in the future be included in Henry Schein's offering to its animal health customers.
Chairman of the Board of Kruuse, Peter Eriksen Jensen said: "We are very pleased with the agreement with Henry Schein, which fulfills our wish to find a strong investor to support our efforts of creating an attractive future for our company. We complement each other extremely well - and the partnership provides us with a much broader platform to market our products. In Henry Schein, we will get an ideal partner to realize our ambitious growth strategy."
Kruuse's CEO, Jesper Smith said: "It is very important to us, that we and our new owner have a mutual understanding of the values and customer-centric focus on quality and services which have guided us throughout Kruuse's 119 years' history. We will continue this approach under our new ownership, making sure that our employees, customers, and suppliers continue to experience all the benefits of Kruuse - now in an even stronger set-up and with new, exciting prospects for the future."
The Society for Practising Veterinary Surgeons (SPVS) has published its 2015 Fee Survey, which has revealed an increasing divergence between fees charged for routine and unroutine procedures in small animal practice.
SPVS says that small animal practices accounted for the largest proportion of responses to its survey, and that 75.9% of them had increased their fees during the last 12 months. When comparing a 'bundle' price comprising a kitten vaccination course, puppy vaccination course, cat spay, dog spay and consultation, the increase was 4.09%. However SPVS notes that this increase may be artificially low, as it relates to the sort of procedures that are regularly quoted and may therefore be constrained by the marketplace.
Perhaps more revealingly, whilst routine procedures such as vaccination had risen 3.3%, non routine procedures had risen by considerably more: pyometras were up 15.6%, cat dentals were up 17.5% and out-of-hours callouts were up 18.6%.
Equine fees showed an overall drop of 3.5% on the bundle price comprising initial routine examination, five-stage PPE, routine dental examination and float, a colic examination and the cost of sedation / waiting. Although many of the individual equine procedures showed a fee decrease, 79% of equine practices reported that they had increased fees over the past year. The largest decrease in equine fees was for sedating a horse and waiting while the horse was clipped or treated by an equine dental technician, with the fee charged being 12.5% less than last year and ranging from £12.50 to £93.82. Conversely, conducting an ultrasound scan of a mare for pregnancy had increased by 17.3% and ranged from £20 to £62.36.
For large animal vets, the fees are more tightly constrained by the commercial realities of farming and the range of fees quoted tends to be lower. This year, the overall price rise for the bundle of fees comprising routine calving, foot trimming, elective Caesarean and hourly rates for fertility work and herd health schemes was 4.1%. However, only 47.8% of large animal practices reported an increase in fees charged over the last twelve months. The largest increase reported was for paring the hind feet of a cow without sedation, which was up 24.4% and ranged in price from £19 to £70, while issuing a prescription to a farm animal client had decreased by 1.6% and ranged in price from 0 to £48.
Nick Stuart, SPVS president said: "We all know the industry is facing real challenges and this is reflected in the fee survey, with equine practices in particular decreasing many of their prices on last year. However the survey also shows that the fees vets charge vary widely, particularly in the small animal sector. While some of this can be accounted for by differing overheads, it does provide a fascinating insight into the various financial models that exist and challenges practice owners to review how they construct their fees. It also suggests that there is scope for practices to grow their profitability and understanding the market will help them with this.
"We have a new benchmarking service from Veterinary Insights that will help practices to set more accurate fee levels and we will be developing our fee survey further so that it dovetails with this service. I would urge practices to join SPVS and access the invaluable data we produce to help them grow their businesses."
For more information, a copy of the survey, or to join SPVS visit www.spvs.org.uk
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, is running an essay competition with a prize of an all-expenses-paid trip to the London Vet Show (London Olympia, 19th-20th November).
To win, you need to submit an essay of 1000 words or less which outlines an idea that will transform the veterinary/veterinary nursing profession by 2030. The College suggests that entrants might might look at a new business model, a new approach to education, a technological innovation or perhaps a way that the working lives of those in the practice team could be improved.
Anyone with an interest in the veterinary profession can enter the competition, including veterinary surgeons, nurses, practice managers and students.
The entries will be judged by the Vet Futures Project Board, which includes the Presidents and Chief Executives of both the Royal College of Veterinary Surgeons and the British Veterinary Association.
Entries will be anonymised then scored on a range of criteria, including originality, potential impact for the future and realistic prospects of change. The winning entry will be placed in a time capsule, to be opened by the veterinary profession in 2030.
The closing date for entries is midnight on Monday 31 August 2015, and the winner will be notified on Monday 7 September 2015.
The full rules and details of how entries can be submitted can be found on www.vetfutures.org.uk/essaycomp.
Gardner Llewlyn Veterinary Recruitment and VetSurgeon.org / VetNurse.co.uk have announced the winners of a competition in which people were invited to nominate nurses for a special thanks for the work they do.
67 entries from veterinary surgeons, veterinary nurses and pet owners made it onto the shortlist.
Jonathan Lewis from Gardner Llewlyn said: "I know it's a cliche, but it really was very hard to pick an outright winner. In the end, though, we just loved the sheer enthusiasm of Peter Howarth MRCVS's nomination for Louisa Bouchard RVN (pictured right) from the New Era Veterinary Hospital, and thought it takes a very special person to inspire the ringing endorsement of her work."
The team nomination was similarly difficult to pick. However, Stephanie Fursland MRCVS's nomination for the nursing team at The Oval Pet Centre stood out as an example of how a good nursing team can have a really profound effect on other members of the practice team.
A new iPad mini is on its way to Louisa, and a case of champagne is winging its way to The Oval Pet Centre. There was also a draw amongst all the nominators to win another iPad mini, the winner of which was Val Marsh, who nominated Kate Slack RVN from Blacks Veterinary Group.
Arlo Guthrie, Editor of VetSurgeon.org and VetNurse.co.uk said: "We found a lot of the entries really rather moving and whether they came from members of the public or from colleagues in the profession, they all serve to demonstrate the importance - as if anyone needed reminding - of what a good nurse brings to the practice. The nominees should all be very proud.
"We decided that the nominations were too good to keep to ourselves, so we've published them on a publicly visible part of VetNurse (click here), with links back to the nominated practices' websites. Hopefully, it might be a nice thing for any of the nominees to add to their CV, and the links should in time result in these lovely endorsements appearing when people make a relevant search for the practice."
A group of some of the best-known referral practices in the country has issued a formal response to the recent announcement by pet insurance underwriter RSA that it is building a network of preferred referral practices to direct its clients to.
Whilst RSA has clarified the contents of a letter it sent to practices in the Midlands and North West, and apologised to the profession for the confusion it caused, it has not yet responded to any of the other concerns raised by the profession.
Perhaps chief amongst those is the claim by RSA's Head of Pet Claims, Keith Maxwell, that the company is looking to provide like-for-like treatment at a lower cost from its list of preferred referral practices.
Referral vets from Anderson Moores Veterinary Specialists in Hampshire, Cave Veterinary Specialists in Somerset, Davies Veterinary Specialists in Hertfordshire, Dick White Referrals in Suffolk, North Downs Specialist Referrals in Surrey, The Veterinary Cardiorespiratory Centre in Warwickshire and Willows Veterinary Centre in the West Midlands say that RSA's current list is simply not representative of the RCVS Recognised Specialist expertise and advanced therapies available within the veterinary profession, thereby making it impossible for RSA to offer like-for-like treatment, let alone at a lower cost.
Clive Elwood, Managing Director of Davies Veterinary Specialists in Hertfordshire, speaking on behalf of the practices who have expressed concern about the move, said: "An approach that focuses on cost-cutting rather than quality of patient care and lacks any genuine or objective process to benchmark clinical standards is inappropriate. Many multi-disciplinary centres place enormous value on the importance of Recognised Specialists being involved at every level of care including consultation, anaesthesia and imaging assessment and the proposed restrictions may preclude this level of service in some instances. We understand that balancing high standards of care and affordability for owners and insurance companies is an important issue and we hope insurers will work with all sectors of the profession to find constructive workable long term solutions."
Mike Martin of the Veterinary Cardiorespiratory Centre in Warwickshire added: "Owners buy pet insurance to ensure that they can access the best available expertise when their animals are ill. I don't think any owner wants to have their choice of practice restricted by insurance companies who are primarily concerned with encouraging shortcuts to reduce costs."
The British College of Veterinary Specialists has invited RSA to attend a meeting to discuss issues of concern, but says it hasn't thus far received a reply.
The RCVS has announced the launch of a consultation on the new proposed list of 'day-one' clinical skills needed by veterinary nurses when they first enter practice.
The College says it welcomes comments on the new list from veterinary nurses, veterinary surgeons and all those involved in veterinary nurse training and education.
The current Day-One Skills document was developed by RCVS Awards, the College's awarding body, in 2010 and provides a list of those skills student veterinary nurses are expected to have gained by the end of their training, and to be competent and confident in when they first go into practice.
As RCVS Awards will be closed by the end of this year, the RCVS is taking the opportunity to review the Day One Skills to bring them closer into line with our recently revised Day One Competences, and to reduce the number of required skills in order to make it more relevant to clinical practice.
Julie Dugmore, Head of Veterinary Nursing, said: "The current document was developed from an awarding body perspective and not that of the regulator, so it specifies a large number of non-clinical skills, for example, handling and moving equipment safely, which, while important, are somewhat out of our regulatory remit.
"Given the wide variety of veterinary practice settings to which student veterinary nurses are exposed, it is important that we, as the industry regulator, define the required day-one skills and ensure that these align with the required day-one competences. We need to review the skills list to ensure consistency, that it reflects current practice, and that it only includes those skills deemed necessary for registration purposes. A clearer focus on safe and effective clinical skills would support our primary regulatory role: that of protecting animal welfare and the public interest."
The consultation sets out the proposed Day-One Skills, grouped according to the corresponding day-one competences, and asks for feedback on their relevance, accuracy and completeness. Comments would be welcomed from higher education institutions, awarding organisations, centres, and training practices, as well as veterinary nurses and veterinary surgeons.
The consultation is available via the RCVS website at www.rcvs.org.uk/consultations and the deadline for responses is 5pm on 29 July 2015.
Zoetis has announced the launch of Contacera (meloxicam) 15mg/ml oral suspension, a non-steriodal anti-inflammatory preparation for horses.
According to the company, meloxicam has been shown to hold advantages over Phenylbutazone for the alleviation of musculoskeletal inflammation and pain in horses over six weeks of age1,2,3,4.
Contacera can be mixed with food or syringed directly into the mouth to ensure compliance. It is available in 100ml or 250ml bottles, with a measuring dose syringe and a syringe adaptor. Contacera solution for injection is also available.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "Contacera is an exciting addition to our NSAID portfolio. Due to the potential clinical advantages of Meloxicam, Contacera gives vets an important additional option for NSAID management. It is a logical fit with the other products in our range and benefits from a choice of presentations."
For further information, contact your Zoetis Account Manager, visit www.zoetis.co.uk, or ring Zoetis' Customer Support: 0845 3008034
References
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
The RCVS has announced that those veterinary surgeons who wish to gain the middle tier RCVS Advanced Practitioner status will have extra time to do so this year.
The status, which was launched last August, recognises those veterinary surgeons who can demonstrate knowledge and skills beyond their initial degree in a designated field of veterinary practice. This year the application process, which opens today, will end on Friday 30 October, meaning that veterinary surgeons will have over four months to submit their application, compared to less than three months last year.
Christine Warman, Head of Education at the College, said: "Following on from the great success of our first ever application process last year, in which some 640 vets applied of whom 575 were successful, we have decided to lengthen this year's application window. We hope that this will allow prospective applicants extra time to consider and make an application."
Applications received in June and July will be considered by the Advanced Practitioner Panel and, where successful, ratified by the RCVS Education Committee in October this year, which may result in an earlier listing for successful applicants. Successful applications received in August, September and October will be ratified at the Education Committee's February 2016 meeting.
This year veterinary surgeons will be able to make an application for Advanced Practitioner status through the online 'My Account' area on the RCVS website (www.rcvs.org.uk/login). The fee payable on application is £80 and the RCVS can also now take payment online.
Details of the application process, eligibility criteria, eligible qualifications and fee information, as well as a list of designations, can be found in the Advanced Practitioner Applicant Guidance Notes document which is available to download from www.rcvs.org.uk/advanced
Those who are interested in applying can also contact Duncan Ash, RCVS Education Officer, for an initial discussion on 020 7202 0703 or d.ash@rcvs.org.uk
Spanish company Vital Dinamic has announced the launch of SD VET, a new stool designed to reduce the physical stress from prolonged standing whilst operating.
The stool is based on a multi-directional rocking design which gives the surgeon a wide range of movement whilst taking the weight off their legs (see video below).
In addition, the company says that SD VET protects the back from postural problems, helps circulation in the legs and puts the surgeon in a more relaxed posture, thereby helping to improve concentration on the task at hand.
For more information, contact: José de Benito, International Sales Director on +34 661 763 887 or email: jdebenito@vitaldinamic.com
The Copper Development Association (CDA) reports that a Harare veterinary practice has become the first in Zimbabwe to add copper touch surfaces to its suite of infection prevention measures.
24 Hour Veterinary Practice opted to replace frequently-touched surfaces including table tops, drawer handles, light and electrical switches, chair arms, desk tops and even mice with solid copper equivalents.
The CDA says copper is a powerful antimicrobial with rapid, broad-spectrum efficacy against bacteria and viruses, including MRSA, E.coli and norovirus (references). It shares this benefit with a range of copper alloys - including brasses and bronzes - forming a family of materials collectively called 'antimicrobial copper'.
Touch surfaces made from solid antimicrobial copper are used by healthcare facilities around the world to reduce the spread of infections such as norovirus and MRSA, supporting key infection control measures such as good hand hygiene and frequent surface cleaning and disinfection.
Dr Vinay Ramlaul, who runs the practice, said: 'We're very pleased with the copper touch surfaces. They're easy to clean and present a bright, sterile image to our clients. We feel secure knowing that copper is continuously killing microbes being transmitted to the surfaces by both our clients and patients.'
24 Hour Veterinary Practice joins a number of other veterinary facilities in South Africa already using antimicrobial copper surfaces to enhance hygiene. The CDA says it is not aware of any UK practices that have yet installed the surfaces, although it is being used in a number of human healthcare hospitals and clinics in the UK.
For more information, including a list of antimicrobial copper products and suppliers, visit www.antimicrobialcopper.org.
The RCVS has announced that its Professional Standards Advice Team, which offers advice about the Code of Professional Conduct and its supporting guidance, is now trialling extended hours and remaining open until 7pm Monday to Friday.
The trial will last for three months.
The closing time of 7pm was decided by the RCVS Standards Committee because research conducted by both the Society of Practising Veterinary Surgeons and the RCVS determined that this is the average closing time for veterinary practices in the UK.
On average the Professional Conduct Department deals with 7,500 calls a year (which includes calls from veterinary surgeons and veterinary nurses looking for advice about professional responsibilities and standards) as well as around 2,000 written requests which are dealt with exclusively by the Professional Standards Advice Team.
Laura McClintock, Standards and Advisory Manager, said: "The aim of the trial is to determine if the profession would take advantage of these extended hours and, therefore, if our team should permanently extend its operating hours to provide a better service to the profession.
"However, it must be remembered that this is not an emergency service but an extension to our standard service and advice during the extended hours will not necessarily be any more immediate than at any other time during the day because it may need further research or input from members of the Standards Committee.
"Prior to launching the trial we also liaised with 10 other UK healthcare and professional regulators and found that our current professional advice service compared favourably to others and that we were providing a more extensive service than many."
The team aims to provide clear, concise and consistent advice to help veterinary surgeons and veterinary nurses understand their professional responsibilities and support compliance with the Code. It also distinguishes between professional requirements, legal requirements and suggested good practice and may offer suggestions about how professional responsibilities can be applied in practice.
However, there are some areas on which the team is unable to offer guidance. For example, it cannot offer clinical advice or advice on legal matters such as employment law, maternity rights, or contractual or civil disputes.
Advice is also available for members of the public, for example, to help animal owners understand what they can expect from their veterinary surgeons and veterinary nurses.
To contact the team call 020 7202 0789 or, alternatively, email profcon@rcvs.org.uk
Improve International has launched 'Fast-Track' Postgraduate Certificate (PgC) Programmes, designed for veterinary surgeons who wish to take an immersive approach to study and complete the taught components in either its Small Animal Medicine or Small Animal Surgery programmes in three months.
The new programmes are set to begin in October 2015 with each able to accommodate a maximum of 12 delegates drawn from across Europe. In developing the content programme to suit a three month study period, Improve says it has added a range of features, including a dedicated mentor to support delegates.
The content for both the Small Animal Medicine and Small Animal Surgery Fast-Track PgC programmes is the same as the PgC programmes Improve runs over two years with the difference of the completion of the taught modules in three months. The programme then follows the normal PgC programme, with the completion of case reports, case studies and an examination, in order to gain a PgC. The Medicine PgC programme also includes additional practical sessions covering ophthalmology and diagnostic imaging, plus other core practical skills.
Practical training sessions for the Medicine Fast-Track programme will take place at Improve's Training Centre in Swindon while classroom-based sessions will be held at the Farmers' Club on the Embankment in Central London for ease of access. Delegates undertaking the Surgery programme will also be able to undertake practical sessions at Improve's facility at the John Krebs Field Station, Wytham, near Oxford. In addition to the tutored sessions, delegates on the Surgery programme will see practice with a subject expert for ten days, with the opportunity of scrubbing in to assist in soft tissue and orthopaedic surgical procedures.
To support delegates interested in the PgC Small Animal Medicine and Small Animal Surgery programmes, Improve has created a new website at www.vetpgc.co.uk.
David Babington MRCVS, Managing Director of Improve, said: "While vets generally take a PgC over a two year period in order to combine it with work commitments, there are circumstances in which it may be preferable to take some blocks of time out and complete the taught lectures in a shorter period of intensive study. Vets can be applying the new techniques in their practice after just three months and can gain a PgC in just one year.
"We wanted to offer this alternative study route to vets and have been working for some time to develop a consolidated three month version of both our Medicine and Surgery PgC training programmes. We're delighted to able to launch these exciting new programmes and look forward to welcoming our first cohort of delegates in October 2015."
For further information, visit www.vetpgc.co.uk or www.improveinternational.com or call 01793 759159.
RSA Insurance Group, which underwrites pet insurance on behalf of MORE TH>N, Tesco Bank, M&S, John Lewis, Argos and Homebase, has clarified recently announced changes to its policy conditions concerning cases which need to be referred for specialist treatment.
In a letter dated 22nd May, which was sent to practices in the Midlands and the NW, the company said:
"With effect from the 25th May 2015, if you need to refer a pet under any of the above Brands to a specialist or referral vet, and the visit is not in response to an emergency, then our customer / your Client can contact us on the relevant number below before any appointment is made. We will then agree which of our preferred specialist or referral practices our customer should go to, dependant (sic) on the individual circumstance relating to the claim. If our customer does not get in touch with us or we have not agreed to the visit, then this could result in our customer suffering a financial impact. This amount will be in addition to the policy excess."
Speaking to VetSurgeon.org, Keith Maxwell, Head of Pet Claims at RSA said: "What we're saying to the primary practices is that we want to speak to our customers before they go to a referral vet. We want to engage with our customers to let them know that we have referral vets who we are starting to work with across those specific regions. We are not saying to customers that you have to use those referral vets and if you don't, we won't provide cover."
This appeared to contradict a statement that a member of VetSurgeon.org had received from John Lewis earlier which said: “If you decided to go to a specialist that wasn’t approved by us, we wouldn’t cover the costs." Keith said: "That is not correct."
Clarifying the financial impact referred to in the company's letter to veterinary practices, Keith said: "In terms of any sort of financial impact on the customer, if we think about the level of benefit that a customer will have under their insurance policy, they will have a maximum cash benefit. If a customer goes to one specific referral vet and the cost of treatment is extremely high, and they have a choice of going to a referral vet that we have been interacting with to get a like for like treatment, the cost will be lower, the financial impact on the customer will be that the overall benefit available to them will be eroded at a faster rate."
He added: "The other thing I would say is that certain customers under our policies will have a policy excess which will be on a percentage basis. Now if you think about a higher cost treatment which will incur a percentage excess, it will be a higher amount the customer will have to pay, as opposed to going to a referral vet where they can get the exact same high quality treatment, but the overall cost will be lower; they will pay a lower excess. So we are not saying we are going to penalise a customer. There are other financial consequences i.e. eroding benefit or having to pay a greater amount of excess."
Whilst RSA appears not to be removing the freedom of choice over referrals, there remains the potential for a conflict of interest when a primary practitioner recommends treatment at a centre they believe to be the most suitable for the case, and the client then rings the insurer only to be advised to use an alternative, primarily for reasons of cost. Keith said: "What I would say is that we are at the start of a journey. We've selected a small part of the country. We are very much in a 'test and learn' phase. As we have selected referral vets, we have gone through obviously quite a lengthy process of engaging with referral vets, looking at specialism, looking at their accreditation, looking at their capability, their skill, equipment within their practices, what their areas of specialism are, so we are building up this view. It does come down to we want to learn from this. We want to engage with our customers. We want to offer our customers choice. We want to make sure that our customers will not be receiving an inferior service or inferior treatment or level of specialism in any specific way."
VetSurgeon.org asked how RSA has selected its preferred referral practices, and how others can join its network. Keith said: "When we started this journey, we made contact with a significant number of referral vets across the country. Some referral vets just said point blank 'No, we don't want to talk to you'. Others said 'Yes, we'd like to come and have some discussions'. So we took those forward and then we took the referral vets through a benchmarking process based on a full list of criteria, and within RSA we have veterinary expertise helping us along that journey, so we're not just doing this on our own. We are very much an open door to interacting and liaising with referral vets."
Keith concluded by saying: "We are focused on our customers here. We are focused on making sure that pet insurance is sustainable in the long term, both for our customers and for vets across the country."
Royal Veterinary College research, published in the journal PLOS ONE, has revealed that 1 in 4 cases of Diabetes Mellitus in domestic cats are caused by excess secretion of pituitary growth hormone.
According to the researchers, this is much more common than previously thought. Furthermore, they say that cats with this condition are easily misdiagnosed as having primary (type 2) diabetes mellitus but do not respond to the standard treatment to that condition, resulting in increased morbidity and ultimately leading to euthanasia on welfare grounds.
Researchers collected data between 2003 and 2011 on cats treated at vet practices across the UK, to estimate the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date and look how easy this is to recognise.
Findings revealed that the presence of Diabetes Mellitus in 1 in 4 domestic cats can be explained by hypersomatotropism, which is caused by a pituitary benign tumour and can be effectively treated by one operation in specialist centres.
However only 24% of clinicians who submitted samples suspected that this was the case, as most hypersomatotropism cats did not display typical signs, instead displaying symptoms indistinguishable from cats with primary (type 2) Diabetes Mellitus. This suggests that hypersomatotropism screening should be considered when treating diabetic cats.
Lead researcher, Dr Stijn Niessen from the Royal Veterinary College, said: "It has been common practice to automatically suspect a cat with Diabetes Mellitus to be suffering from a form of diabetes akin to human type 2. The current study suggests that this is an oversimplification. Approximately one in four of assessed diabetic cats were actually found to be suffering from hypersomatotropism-induced Diabetes Mellitus, which requires specific treatment and manifests itself very differently as it develops.
"Interestingly, only a small proportion of clinicians reported they strongly suspected acromegaly to be present on the basis of the clinical picture. These data therefore highlight the need for veterinarians working with the spontaneously diabetic cat to consider routinely screening for the presence of hypersomatotropism-induced Diabetes Mellitus, given the significant clinical consequences of its presence.
"Should the hypersomatotropism be diagnosed and treated with one operation, most cats will enter a state of diabetic remission. If it remains undiagnosed, diabetic cats tend to be difficult to regulate glycaemically which often results in euthanasia, or in the long-term, they will suffer from other growth hormone-induced negative conditions such as heart disease, as well as central nervous system problems."
Evaluation of serum fructosamine was offered free of charge for all diabetic cats attending any veterinary practice in the UK from October 2003 till April 2011. Veterinary surgeons were asked to record clinical data about the patient, including age, breed, gender, current body weight, current administered insulin dose and whether they clinically suspected acromegaly/ hypersomatotropism. Diabetic cats were screened using serum total insulin-like growth factor-1, followed by further evaluation through pituitary imaging and/ or histopathology.
In total, 1221 diabetic cats were screened; 319 (26.1%) had a blood IGF-1 suggestive of hypersomatotropism. Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95%, suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8%.
The paper also suggests that although great opportunities exist for comparative research between primary (type 2) diabetes in cats and humans, researchers should exercise caution in light of these new findings.
Stijn added: "The similarities between feline and human type 2 diabetes emphasise great opportunities for valuable comparative research benefiting all species into this major disease, which is fast becoming a global epidemic. However our latest research proves that there is a need for more regular hypersomatotropism screening, to identify the root cause of diabetes in domestic cats before samples are used, so as not to corrupt results."
Scrubs Etc Limited has announced the launch of Steribond, a new skin adhesive notable for the fact that it is sterile and can be stored at ambient temperature for up to 18 months.
The product has so far only been launched to a limited number of people at the London Vet Show last November.
According to the company, Steribond is as strong as a 3.0 suture for external sutures and can therefore be used in place of sutures and staples. It has a 10 second setting time, and will stay in place for between 5 to 10 days, depending on the site of injury and other factors.
The product has a precision applicator with a transparent reservoir, allowing the user to see how much adhesive is available and that the applicator is primed. The company says that it allows for a cosmetically neater wound closure, which can be important to customers. In addition, it is a no-sting product which Scrubs Etc says can remove the need to sedate the animal in come circumstances, thereby reducing costs. Steribond is also showerproof.
Steribond is currently on special offer, priced at £83.64 (usual price £102.00 incl. VAT).
For more information, contact Scrubs Etc Ltd on 0870 080 2332 or see: http://www.scrubsuk.com/steribond-veterinary-skin-adhesive-box-of-10-devices.html
Petplan has teamed up with Battersea Dogs & Cats Home to launch Summer Safety, a pet owner education campaign based on insurance claims received by the company.
The company reports that last year, 83% of all heat stroke claims occurred in the summer months (June-August), with 48% of them in July alone. Almost half of all heat stroke claims last year came in at an average of £315, with the highest claim reaching nearly £600.
80% of grass seed claims happened between June and August last year, 41% of which happened in July. The highest grass seed claim paid out by Petplan last year was just over £3,600, with the top ten highest grass seed claims totalling over £18,500.
Petplan says it also sees a significant spike in claims for injuries resulting from other foreign bodies in ears and paws in the summer months. Last year, 77% of claims arising from foreign bodies in ears and 55% for foreign bodies in paws occurred between June and August.
In order to alleviate the risk to pets and highlight the danger, Petplan and Battersea Dogs & Cats Home have created a guide to help pet owners determine how at-risk to heat their pet is. The guide is available to download at petplan.co.uk/summersafety and Battersea.org.uk/funinthesun.
Petplan's vet Brian Faulkner MRCVS said: "Using the simple four step process, the guide encourages pet owners to answer a series of questions that reveals their pet's SPF score, whilst including useful tips to help keep their pet out of harm's way during the hotter months. The scale calculates a pet's risk to retaining heat based on four factors, those being; coat colour, coat type, length of the animal's nose and its age, to determine either a low, medium or high risk susceptibility."
The RCVS has launched the recruitment process for new Practice Standards Scheme (PSS) Assessors, ahead of the Scheme's relaunch in November this year.
The College is looking to recruit 18 experienced veterinary surgeons as Assessors who will work directly with RCVS-accredited practices to help them comply with the Scheme and maintain the highest possible standards of veterinary care.
Successful candidates will be expected to actively assess and inspect veterinary practices at the different PSS accreditation levels - core, general practice and hospital - to encourage continuous improvement; they will work proactively with practice teams to ensure that the Scheme's standards are understood and being worked towards. The College is aiming to recruit Assessors from across the UK who have experience in small animal, equine and/or farm animal practice.
An Open Day will be held at the RCVS on Friday, 12 June 2015, to give prospective candidates more information about the roles. Anyone interested in attending should contact Alicia on 020 7202 0786 or email atAliciaM@rcvs.org.uk. As places are limited, they will be allocated on a first-come, first-served basis.
The recruitment process is being handled by Thewlis Graham Associates. Those interested in applying should contact them for a confidential discussion on 020 7850 4781. The deadline for applications is Monday, 29 June 2015.
Further information about the role, including the candidate brief and application form, is available at www.thewlisgraham.com.
Northwest Surgeons, the Cheshire-based referral centre which is now part of Pets at Home, has announced the expansion of its clinical specialisms into the field of neurology, with the appointment of Dr Lorenzo Golini.
Dr Golini underwent residency training in neurology and neurosurgery at the University of Zurich where he remained as a clinician after his residency. He holds the European Diploma in Veterinary Neurology and a Master's degree in behavioural medicine. His main interests lie in epilepsy and MRI.
Dr Chris May, Northwest Surgeons' Managing Director said: "Neurology is a natural extension of the services we offer currently and is an area of growth in response to an increased demand from our referring vets. I am delighted to welcome Lorenzo to our team."
Dr Golini will accept referrals for both medical and surgical neurology cases, expanding on the case load seen by Northwest Surgeons' existing specialist teams which offer referrals in orthopaedic, soft tissue and spinal surgery and internal medicine. These services are supported by veterinary specialists in anaesthesia, pain management and diagnostic imaging.
For more information, visit: www.nwsurgeons.co.uk
Bayer Animal Health has announced the launch of Ceffect (cefquinome), for the treatment of bacterial infections in cattle and pigs caused by Gram-positive and Gram-negative micro-organisms sensitive to cefquinome.
Ceffect is available as a 25mg/ml suspension for injection of cattle and pigs, and as Ceffect LC, a 75mg intramammary ointment for lactating cows.
In cattle, Ceffect 25mg/ml suspension for injection is licensed for the treatment of respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica, and also for the treatment of digital dermatitis, infectious bulbar necrosis, acute interdigital necrobacillosis, and acute E.coli mastitis with signs of systemic involvement.
In calves, Ceffect 25mg/ml suspension for injection is licensed for the treatment of E.coli septicaemia
In pigs, Ceffect 25mg/ml suspension for injection targets cefquinome-sensitive organisms including Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae and Streptococcus suis which can cause bacterial infections of the lungs and respiratory tract. It is also licensed for the treatment of Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of E.coli, Staphylococcus spp., Streptococcus spp. and other cefquinome-sensitive organisms.
In piglets, Ceffect 25mg/ml suspension is licensed for the reduction of mortality in cases of meningitis caused by Streptococcus suis. For the treatment of arthritis caused by Streptococcus spp., E. coli and other cefquinome-sensitive organisms, and epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.
Ceffect LC, 75mg intramammary ointment for lactating cows also contains cefquinome and comes in individual 8g prefilled syringes for treatment of clinical mastitis caused by Streptococcus uberis, Streptococcus dysgalactiae, Staphylococcus aureus and E. coli, in lactating dairy cows.
For further product information, visit www.noahcompendium.co.uk or contact your local Bayer territory manager.